Peptide record

TPDB09309

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09309
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
CRFCCRCCPRMRGCGLCCRF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C92H153N35O21S9
ANDEQHIKSTWYV
C
2373.99
8.54
5
0
4
+5
2.46
0.320
19.50
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
500
0.21
8
Residue Composition
number
0
A
5
R
0
N
0
D
8
C
0
E
0
Q
2
G
0
H
0
I
1
L
0
K
1
M
2
F
1
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 8 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 1 K: 0 M: 1 F: 2 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
20 reviewed residue count
C92H153N35O21S9 sequence-only estimate (linear, free termini)
2373.99 sequence-only estimate (linear, free termini)
8.54 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
2.46 sequence-only estimate (linear, free termini)
0.320 sequence-only estimate (linear, free termini)
Evidence Records 8 records
Evidence 1 Activity

Activity

IC50
Antibacterial
11.41 µM

Target

B. subtilis CECT 35

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
11 (IC50 2.2 uM), 51M6 (IC50 14.61 uM) (both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition
Evidence 2 Activity

Activity

IC50
Antibacterial
18.66 µM

Target

Escherichia coli DH5alpha

Source & Reference

dbAMP DRAMP

Other

both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition after 12 h incubation. The viability
Evidence 3 Activity

Activity

IC50
Antifungal
11.41 µM

Target

B. subtilis CECT 35

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
11 (IC50 2.2 uM), 51M6 (IC50 14.61 uM) (both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition
Evidence 4 Activity

Activity

IC50
Antifungal
18.66 µM

Target

Escherichia coli DH5alpha

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition after 12 h incubation. The viability
Evidence 5 Activity

Activity

IC50
Antiparasitic
11.41 µM

Target

B. subtilis CECT 35

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
11 (IC50 2.2 uM), 51M6 (IC50 14.61 uM) (both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition
Evidence 6 Activity

Activity

IC50
Antiparasitic
18.66 µM

Target

Escherichia coli DH5alpha

Source & Reference

DRAMP

Other

both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition after 12 h incubation. The viability
Evidence 7 Activity

Activity

IC50
Antiviral
11.41 µM

Target

B. subtilis CECT 35

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
11 (IC50 2.2 uM), 51M6 (IC50 14.61 uM) (both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition
Evidence 8 Activity

Activity

IC50
Antiviral
18.66 µM

Target

Escherichia coli DH5alpha

Source & Reference

DRAMP

Other

both isolates belonging to the genus Shewenella), B. subtilis CECT 35 (IC50 11.41 uM) and E. coli DH5alpha (IC50 18.66 uM). IC50 is the concentration for 50% growth inhibition after 12 h incubation. The viability